Arabic Arabic English English French French German German
dark

Medicare proposes to only cover Alzheimer’s drug aduhelm for use in clinical trials

(HealthDay)—It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

BinaxNOW test catches COVID infection in many people, study shows

Next Post

Selected procedures may be performed by surgical residents alone

Related Posts
Total
0
Share